Home

Julie L. Gerberding

CIK 1628884 · EVP, Chief Patient Officer · last filed 2026-07-23

Julie L. Gerberding is an EVP, Chief Patient Officer who has filed 40 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for MCK, was dated Jul 23, 2026. Across all open-market trades the lifetime net is −$31.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.25M

Companies

4

Total Filings

40

Lifetime Open-Market Net

-$31.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MCK Director — $877.23 — $0 3 2026-07-23
HilleVax, Inc. (HLVX) Delisted Director 0 $2.09 $0 $0 5 2025-09-17
CERNER Corp (CERN) Delisted Director 0 $94.92 $0 -$569.4K 8 2022-06-09
MRK EVP, Chief Patient Officer 48,712 $128.33 $6.25M -$31.27M 24 2022-02-28

Recent Filings

40 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-23 MCK Grant (A) — $0 EDGAR
2025-09-17 HilleVax, Inc. (HLVX) Delisted U −59,224 $0 EDGAR
2025-07-31 MCK Grant (A) — $0 EDGAR
2025-06-25 HilleVax, Inc. (HLVX) Delisted Grant (A) +17,199 $0 EDGAR
2025-04-30 HilleVax, Inc. (HLVX) Delisted Grant (A) — $0 EDGAR
2025-02-10 MCK Grant (A) — $0 EDGAR
2023-06-09 HilleVax, Inc. (HLVX) Delisted Grant (A) — $0 EDGAR
2022-08-23 HilleVax, Inc. (HLVX) Delisted Grant (A) — $0 EDGAR
2022-06-09 CERNER Corp (CERN) Delisted U −15,032 -$1.43M EDGAR
2022-02-28 MRK Grant (A) +9,550 $702.0K EDGAR
Showing 1–10 of 40
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.